GenVec, Inc.
(NASDAQ:GNVC)|
0.520 -0.020 (-3.70%) 12:28ET Delayed |
|
|
|
- Compare GNVC with:
- View: Line | Candlestick
Company Profile
GenVec, Inc.
65 West Watkins Mill Road
Gaithersburg, MD 20878
United States - Map
Phone: (240) 632-0740
Fax: (240) 632-0735
Website: www.genvec.com
State of incorporation: Delaware
CEO: Dr. Paul H. Fischer, Ph.D.
Employees: 119
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Gene-therapy company
A clinical stage biopharmaceutical company working to develop and commercialize innovative gene-based therapies to treat cancer, vision and hearing loss and balance disorders, and vaccines to prevent infectious diseases.
Recent news for GNVC
-
TheStreet.com - Dec 29 2008 at 12:20 ET
-
PR Newswire - Dec 05 2008 at 8:30 ET
-
GENVEC INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online - Nov 21 2008 at 4:13 ET
-
[$$] Biotech Mailbag: Recap on GenVec
RealMoney by TheStreet.com - Nov 21 2008 at 7:45 ET
-
Autumn babies at greater risk of asthma - US study
Reuters - Nov 21 2008 at 1:00 ET
-
GenVec Stock Hit by Pancreas Study's Details
TheStreet.com - Nov 19 2008 at 1:40 ET
-
GenVec reports promising results from drug tests
bizjournals.com - Nov 19 2008 at 9:05 ET
-
CCBN - Nov 19 2008 at 9:00 ET
-
Business Wire - Nov 19 2008 at 6:50 ET
-
EDGAR Online Financials - Nov 13 2008 at 9:04 ET